These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 15105971)
1. The effect of nicotine on basophil histamine release. Thompson-Cree ME; Stevenson MR; Shields MD; Ennis M Inflamm Res; 2004 May; 53(5):211-4. PubMed ID: 15105971 [TBL] [Abstract][Full Text] [Related]
2. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. Cirillo R; Triggiani M; Siri L; Ciccarelli A; Pettit GR; Condorelli M; Marone G J Immunol; 1990 May; 144(10):3891-7. PubMed ID: 1692065 [TBL] [Abstract][Full Text] [Related]
3. The mechanism of mediator release from human basophils induced by platelet-activating factor. Columbo M; Casolaro V; Warner JA; MacGlashan DW; Kagey-Sobotka A; Lichtenstein LM J Immunol; 1990 Dec; 145(11):3855-61. PubMed ID: 1700998 [TBL] [Abstract][Full Text] [Related]
4. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells. Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332 [TBL] [Abstract][Full Text] [Related]
6. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. Kuna P; Reddigari SR; Schall TJ; Rucinski D; Viksman MY; Kaplan AP J Immunol; 1992 Jul; 149(2):636-42. PubMed ID: 1378073 [TBL] [Abstract][Full Text] [Related]
7. In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils. Casolaro V; Spadaro G; Patella V; Marone G J Immunol; 1993 Nov; 151(10):5563-73. PubMed ID: 7693814 [TBL] [Abstract][Full Text] [Related]
8. Reduced priming effect of interleukin 3 on IgE mediated basophil histamine release in patients with systemic sclerosis. Tedeschi A; Salmaso C; Milazzo N; Miadonna A J Rheumatol; 1998 Jul; 25(7):1320-4. PubMed ID: 9676763 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of basophil histamine release by anti-inflammatory steroids. II. Studies on the mechanism of action. Schleimer RP; MacGlashan DW; Gillespie E; Lichtenstein LM J Immunol; 1982 Oct; 129(4):1632-6. PubMed ID: 6180017 [TBL] [Abstract][Full Text] [Related]
11. Increased release of histamine in patients with respiratory symptoms related to perfume. Elberling J; Skov PS; Mosbech H; Holst H; Dirksen A; Johansen JD Clin Exp Allergy; 2007 Nov; 37(11):1676-80. PubMed ID: 17877753 [TBL] [Abstract][Full Text] [Related]
12. The in vitro and in vivo effect of corticosteroids on basophil releasability in patients with mild and severe bronchial asthma. Kivity S; Onn A; Agami O; Fireman E Clin Exp Allergy; 1997 Aug; 27(8):909-14. PubMed ID: 9291288 [TBL] [Abstract][Full Text] [Related]
13. Analyzing histamine release by flow cytometry (HistaFlow): a novel instrument to study the degranulation patterns of basophils. Ebo DG; Bridts CH; Mertens CH; Hagendorens MM; Stevens WJ; De Clerck LS J Immunol Methods; 2012 Jan; 375(1-2):30-8. PubMed ID: 21945198 [TBL] [Abstract][Full Text] [Related]
14. Protein Fv produced during vital hepatitis is a novel activator of human basophils and mast cells. Patella V; Bouvet JP; Marone G J Immunol; 1993 Nov; 151(10):5685-98. PubMed ID: 7693815 [TBL] [Abstract][Full Text] [Related]
15. Anti-human IgG causes basophil histamine release by acting on IgG-IgE complexes bound to IgE receptors. Lichtenstein LM; Kagey-Sobotka A; White JM; Hamilton RG J Immunol; 1992 Jun; 148(12):3929-36. PubMed ID: 1376345 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of allergen-induced basophil activation by ASM-024, a nicotinic receptor ligand. Watson BM; Oliveria JP; Nusca GM; Smith SG; Beaudin S; Dua B; Watson RM; Assayag EI; Cormier YF; Sehmi R; Gauvreau GM Int Arch Allergy Immunol; 2014; 165(4):255-64. PubMed ID: 25660404 [TBL] [Abstract][Full Text] [Related]
17. The mechanism of basophil histamine release induced by pepstatin A. Marone G; Columbo M; Soppelsa L; Condorelli M J Immunol; 1984 Sep; 133(3):1542-6. PubMed ID: 6205086 [TBL] [Abstract][Full Text] [Related]
18. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus. Lourenço FD; Azor MH; Santos JC; Prearo E; Maruta CW; Rivitti EA; Duarte AJ; Sato MN Br J Dermatol; 2008 May; 158(5):979-86. PubMed ID: 18341658 [TBL] [Abstract][Full Text] [Related]
19. Expression of actin and tubulins in purified human basophil leukocytes upon stimulation with IL-3. Nielsen HV; Johnsen AH; Schiøtz PO Int Arch Allergy Immunol; 2004 Apr; 133(4):340-7. PubMed ID: 15031607 [TBL] [Abstract][Full Text] [Related]
20. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]